Toll Free: 1-888-928-9744

2013-2028 Report on Global Anti-tumor Drug Market by Player, Region, Type, Application and Sales Channel

Published: Aug, 2019 | Pages: 119 | Publisher: MAResearch
Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)

The global Anti-tumor Drug market was valued at $XX million in 2018, and MAResearch analysts predict the global market size will reach $XX million by the end of 2028, growing at a CAGR of XX% between 2018 and 2028.

This report provides detailed historical analysis of global market for Anti-tumor Drug from 2013-2018, and provides extensive market forecasts from 2019-2028 by region/country and subsectors. It covers the sales volume, price, revenue, gross margin, historical growth and future perspectives in the Anti-tumor Drug market.

Leading players of Anti-tumor Drug including:
    Roche
    Novartis
    Celgene
    Bristol-Myers Squibb
    Amgen
    Johnson & Johnson
    Pfizer
    Takeda
    Eli Lilly
    AstraZeneca
    Astellas
    Merck & Co
    Sanofi
    Bayer
    Biogen Idec
    Eisai
    Teva
    Otsuka

Market split by Type, can be divided into:
    Cytotoxic Drugs
    Non-cytotoxic Drugs

Market split by Application, can be divided into:
    Alkylating Agents
    Anti-metabolism Drugs
    Platinum Antineoplastic Agents
    Anthracycline antitumor drugs
    Microtubule Stabilizer
    Endocrine Therapy Drugs

Market split by Sales Channel, can be divided into:
    Direct Channel
    Distribution Channel

Market segment by Region/Country including:
    North America (United States, Canada and Mexico)
    Europe (Germany, UK, France, Italy, Russia and Spain etc.)
    Asia-Pacific (China, Japan, Korea, India, Australia and Southeast Asia etc.)
    South America Brazil, Argentina, Colombia and Chile etc.)
    Middle East & Africa (South Africa, Egypt, Nigeria and Saudi Arabia etc.)

If you have any special requirement, please let us know and we can provide you the report as your requirement.

 Table of Contents

Chapter 1 Anti-tumor Drug Market Overview
    1.1 Anti-tumor Drug Definition
    1.2 Global Anti-tumor Drug Market Size Status and Outlook (2013-2028)
    1.3 Global Anti-tumor Drug Market Size Comparison by Region (2013-2028)
    1.4 Global Anti-tumor Drug Market Size Comparison by Type (2013-2028)
    1.5 Global Anti-tumor Drug Market Size Comparison by Application (2013-2028)
    1.6 Global Anti-tumor Drug Market Size Comparison by Sales Channel (2013-2028)
    1.7 Anti-tumor Drug Market Dynamics
        1.7.1 Market Drivers/Opportunities
        1.7.2 Market Challenges/Risks
        1.7.3 Market News (Mergers/Acquisitions/ Expansion)
Chapter 2 Anti-tumor Drug Market Segment Analysis by Player
    2.1 Global Anti-tumor Drug Sales and Market Share by Player (2016-2018)
    2.2 Global Anti-tumor Drug Revenue and Market Share by Player (2016-2018)
    2.3 Global Anti-tumor Drug Average Price by Player (2016-2018)
    2.4 Players Competition Situation & Trends
    2.5 Conclusion of Segment by Player
Chapter 3 Anti-tumor Drug Market Segment Analysis by Type
    3.1 Global Anti-tumor Drug Market by Type
        3.1.1 Cytotoxic Drugs
        3.1.2 Non-cytotoxic Drugs
    3.2 Global Anti-tumor Drug Sales and Market Share by Type (2013-2018)
    3.3 Global Anti-tumor Drug Revenue and Market Share by Type (2013-2018)
    3.4 Global Anti-tumor Drug Average Price by Type (2013-2018)
    3.5 Leading Players of Anti-tumor Drug by Type in 2018
    3.6 Conclusion of Segment by Type
Chapter 4 Anti-tumor Drug Market Segment Analysis by Application
    4.1 Global Anti-tumor Drug Market by Application
        4.1.1 Alkylating Agents
        4.1.2 Anti-metabolism Drugs
        4.1.3 Platinum Antineoplastic Agents
        4.1.4 Anthracycline antitumor drugs
        4.1.5 Microtubule Stabilizer
    4.2 Global Anti-tumor Drug Sales and Market Share by Application (2013-2018)
    4.3 Leading Consumers of Anti-tumor Drug by Application in 2018
    4.4 Conclusion of Segment by Application
Chapter 5 Anti-tumor Drug Market Segment Analysis by Sales Channel
    5.1 Global Anti-tumor Drug Market by Sales Channel
        5.1.1 Direct Channel
        5.1.2 Distribution Channel
    5.2 Global Anti-tumor Drug Sales and Market Share by Sales Channel (2013-2018)
    5.3 Leading Distributors/Dealers of Anti-tumor Drug by Sales Channel in 2018
    5.4 Conclusion of Segment by Sales Channel
Chapter 6 Anti-tumor Drug Market Segment Analysis by Region
    6.1 Global Anti-tumor Drug Market Size and CAGR by Region (2013-2028)
    6.2 Global Anti-tumor Drug Sales and Market Share by Region (2013-2018)
    6.3 Global Anti-tumor Drug Revenue and Market Share by Region (2013-2018)
    6.4 North America
        6.4.1 North America Market by Country
        6.4.2 North America Anti-tumor Drug Market Share by Type
        6.4.3 North America Anti-tumor Drug Market Share by Application
        6.4.4 United States
        6.4.5 Canada
        6.4.6 Mexico
    6.5 Europe
        6.5.1 Europe Market by Country
        6.5.2 Europe Anti-tumor Drug Market Share by Type
        6.5.3 Europe Anti-tumor Drug Market Share by Application
        6.5.4 Germany
        6.5.5 UK
        6.5.6 France
        6.5.7 Italy
        6.5.8 Russia
        6.5.9 Spain
    6.6 Asia-Pacific
        6.6.1 Asia-Pacific Market by Country
        6.6.2 Asia-Pacific Anti-tumor Drug Market Share by Type
        6.6.3 Asia-Pacific Anti-tumor Drug Market Share by Application
        6.6.4 China
        6.6.5 Japan
        6.6.6 Korea
        6.6.7 India
        6.6.8 Southeast Asia
        6.6.9 Australia
    6.7 South America
        6.7.1 South America Market by Country
        6.7.2 South America Anti-tumor Drug Market Share by Type
        6.7.3 South America Anti-tumor Drug Market Share by Application
        6.7.4 Brazil
        6.7.5 Argentina
        6.7.6 Colombia
        6.7.7 Chile
    6.8 Middle East & Africa
        6.8.1 Middle East & Africa Market by Country
        6.8.2 Middle East & Africa Anti-tumor Drug Market Share by Type
        6.8.3 Middle East & Africa Anti-tumor Drug Market Share by Application
        6.8.4 Egypt
        6.8.5 Saudi Arabia
        6.8.6 South Africa
        6.8.7 Nigeria
    6.9 Conclusion of Segment by Region
Chapter 7 Profile of Leading Anti-tumor Drug Players
    7.1 Roche
        7.1.1 Company Snapshot
        7.1.2 Product/Business Offered
        7.1.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)
        7.1.4 Strategy and SWOT Analysis
    7.2 Novartis
    7.3 Celgene
    7.4 Bristol-Myers Squibb
    7.5 Amgen
    7.6 Johnson & Johnson
    7.7 Pfizer
    7.8 Takeda
    7.9 Eli Lilly
    7.10 AstraZeneca
    7.11 Astellas
    7.12 Merck & Co
    7.13 Sanofi
    7.14 Bayer
    7.15 Biogen Idec
    7.16 Eisai
    7.17 Teva
    7.18 Otsuka
Chapter 8 Upstream and Downstream Analysis of Anti-tumor Drug
    8.1 Industrial Chain of Anti-tumor Drug
    8.2 Upstream of Anti-tumor Drug
        8.2.1 Raw Materials
        8.2.2 Labor Cost
        8.2.3 Manufacturing Expenses
        8.2.4 Manufacturing Cost Structure
        8.2.5 Manufacturing Process
    8.3 Downstream of Anti-tumor Drug
        8.3.1 Leading Distributors/Dealers of Anti-tumor Drug
        8.3.2 Leading Consumers of Anti-tumor Drug
Chapter 9 Development Trend of Anti-tumor Drug (2019-2028)
    9.1 Global Anti-tumor Drug Market Size (Sales and Revenue) Forecast (2019-2028)
    9.2 Global Anti-tumor Drug Market Size and CAGR Forecast by Region (2019-2028)
    9.3 Global Anti-tumor Drug Market Size and CAGR Forecast by Type (2019-2028)
    9.4 Global Anti-tumor Drug Market Size and CAGR Forecast by Application (2019-2028)
    9.5 Global Anti-tumor Drug Market Size Forecast by Sales Channel (2019-2028)
Chapter 10 Appendix
    10.1 Research Methodology
    10.2 Data Sources
    10.3 Disclaimer
    10.4 Analysts Certification

List of Tables and Figures

    Figure Anti-tumor Drug Example
    Figure Global Anti-tumor Drug Revenue (Million $) Status and Outlook (2013-2028)
    Figure Global Anti-tumor Drug Revenue (Million $) Comparison by Region (2013-2028)
    Figure Global Anti-tumor Drug Sales Comparison by Type (2013-2028)
    Figure Global Anti-tumor Drug Sales Comparison by Application (2013-2028)
    Figure Global Anti-tumor Drug Sales Comparison by Sales Channel (2013-2028)
    Table Global Anti-tumor Drug Sales by Player (2016-2018)
    Table Global Anti-tumor Drug Sales Market Share by Player (2016-2018)
    Figure Global Anti-tumor Drug Sales Market Share by Player in 2018
    Table Global Anti-tumor Drug Revenue (Million $) by Player (2016-2018)
    Table Global Anti-tumor Drug Revenue Market Share by Player (2016-2018)
    Figure Global Anti-tumor Drug Revenue Market Share by Player in 2018
    Table Global Anti-tumor Drug Average Price by Player (2016-2018)
    Figure Global Anti-tumor Drug Average Price by Player in 2018
    Figure Global Anti-tumor Drug Players Competition Situation - Top 5 Players' Revenue Market Share in 2016
    Figure Global Anti-tumor Drug Players Competition Trends - Top 5 Players' Revenue Market Share in 2018
    Figure Example of Cytotoxic Drugs
    Figure Global Cytotoxic Drugs Sales and Growth Rate (2013-2018)
    Figure Example of Non-cytotoxic Drugs
    Figure Global Non-cytotoxic Drugs Sales and Growth Rate (2013-2018)
    Table Global Anti-tumor Drug Sales by Type (2013-2018)
    Table Global Anti-tumor Drug Sales Market Share by Type (2013-2018)
    Figure Global Anti-tumor Drug Sales Market Share by Type in 2018
    Table Global Anti-tumor Drug Revenue (Million $) by Type (2013-2018)
    Table Global Anti-tumor Drug Revenue Market Share by Type (2013-2018)
    Figure Global Anti-tumor Drug Revenue Market Share by Type in 2018
    Table Global Anti-tumor Drug Average Price by Type (2013-2018)
    Figure Global Anti-tumor Drug Average Price by Type in 2018
    Table Leading Players of Anti-tumor Drug by Type in 2018
    Figure Example of Alkylating Agents
    Figure Global Anti-tumor Drug for Alkylating Agents Sales and Growth Rate (2013-2018)
    Figure Example of Anti-metabolism Drugs
    Figure Global Anti-tumor Drug for Anti-metabolism Drugs Sales and Growth Rate (2013-2018)
    Figure Example of Platinum Antineoplastic Agents
    Figure Global Anti-tumor Drug for Platinum Antineoplastic Agents Sales and Growth Rate (2013-2018)
    Figure Example of Anthracycline antitumor drugs
    Figure Global Anti-tumor Drug for Anthracycline antitumor drugs Sales and Growth Rate (2013-2018)
    Figure Example of Microtubule Stabilizer
    Figure Global Anti-tumor Drug for Microtubule Stabilizer Sales and Growth Rate (2013-2018)
    Table Global Anti-tumor Drug Sales by Application (2013-2018)
    Table Global Anti-tumor Drug Sales Market Share by Application (2013-2018)
    Figure Global Anti-tumor Drug Sales Market Share by Application in 2018
    Table Leading Consumers of Anti-tumor Drug by Application in 2018
    Figure Example of Direct Channel
    Figure Global Anti-tumor Drug for Direct Channel Sales and Growth Rate (2013-2018)
    Figure Example of Distribution Channel
    Figure Global Anti-tumor Drug for Distribution Channel Sales and Growth Rate (2013-2018)
    Table Global Anti-tumor Drug Sales by Sales Channel (2013-2018)
    Table Global Anti-tumor Drug Sales Market Share by Sales Channel (2013-2018)
    Figure Global Anti-tumor Drug Sales Market Share by Sales Channel in 2018
    Table Leading Distributors/Dealers of Anti-tumor Drug by Sales Channel in 2018
    Table Global Anti-tumor Drug Market Size and CAGR by Region (2013-2028)
    Table Global Anti-tumor Drug Sales by Region (2013-2018)
    Table Global Anti-tumor Drug Sales Market Share by Region (2013-2018)
    Figure Global Anti-tumor Drug Sales Market Share by Region in 2018
    Table Global Anti-tumor Drug Revenue (Million $) by Region (2013-2018)
    Table Global Anti-tumor Drug Revenue Market Share by Region (2013-2018)
    Figure Global Anti-tumor Drug Revenue Market Share by Region in 2018
    Table North America Anti-tumor Drug Sales by Country (2013-2018)
    Figure North America Anti-tumor Drug Sales Market Share by Country (2013-2018)
    Table North America Anti-tumor Drug Revenue by Country (2013-2018)
    Figure North America Anti-tumor Drug Revenue Market Share by Country (2013-2018)
    Figure North America Anti-tumor Drug Sales Market Share by Type in 2018
    Figure North America Anti-tumor Drug Sales Market Share by Application in 2018
    Figure United States Anti-tumor Drug Sales and Growth Rate (2013-2018)
    Figure United States Anti-tumor Drug Revenue (Million $) and Growth Rate (2013-2018)
    Figure Canada Anti-tumor Drug Sales and Growth Rate (2013-2018)
    Figure Canada Anti-tumor Drug Revenue (Million $) and Growth Rate (2013-2018)
    Figure Mexico Anti-tumor Drug Sales and Growth Rate (2013-2018)
    Figure Mexico Anti-tumor Drug Revenue (Million $) and Growth Rate (2013-2018)
    Table Europe Anti-tumor Drug Sales by Country (2013-2018)
    Figure Europe Anti-tumor Drug Sales Market Share by Country (2013-2018)
    Table Europe Anti-tumor Drug Revenue by Country (2013-2018)
    Figure Europe Anti-tumor Drug Revenue Market Share by Country (2013-2018)
    Figure Europe Anti-tumor Drug Sales Market Share by Type in 2018
    Figure Europe Anti-tumor Drug Sales Market Share by Application in 2018
    Figure Germany Anti-tumor Drug Sales and Growth Rate (2013-2018)
    Figure Germany Anti-tumor Drug Revenue (Million $) and Growth Rate (2013-2018)
    Figure UK Anti-tumor Drug Sales and Growth Rate (2013-2018)
    Figure UK Anti-tumor Drug Revenue (Million $) and Growth Rate (2013-2018)
    Figure France Anti-tumor Drug Sales and Growth Rate (2013-2018)
    Figure France Anti-tumor Drug Revenue (Million $) and Growth Rate (2013-2018)
    Figure Italy Anti-tumor Drug Sales and Growth Rate (2013-2018)
    Figure Italy Anti-tumor Drug Revenue (Million $) and Growth Rate (2013-2018)
    Figure Russia Anti-tumor Drug Sales and Growth Rate (2013-2018)
    Figure Russia Anti-tumor Drug Revenue (Million $) and Growth Rate (2013-2018)
    Figure Spain Anti-tumor Drug Sales and Growth Rate (2013-2018)
    Figure Spain Anti-tumor Drug Revenue (Million $) and Growth Rate (2013-2018)
    Table Asia-Pacific Anti-tumor Drug Sales by Country (2013-2018)
    Figure Asia-Pacific Anti-tumor Drug Sales Market Share by Country (2013-2018)
    Table Asia-Pacific Anti-tumor Drug Revenue by Country (2013-2018)
    Figure Asia-Pacific Anti-tumor Drug Revenue Market Share by Country (2013-2018)
    Figure Asia-Pacific Anti-tumor Drug Sales Market Share by Type in 2018
    Figure Asia-Pacific Anti-tumor Drug Sales Market Share by Application in 2018
    Figure China Anti-tumor Drug Sales and Growth Rate (2013-2018)
    Figure China Anti-tumor Drug Revenue (Million $) and Growth Rate (2013-2018)
    Figure Japan Anti-tumor Drug Sales and Growth Rate (2013-2018)
    Figure Japan Anti-tumor Drug Revenue (Million $) and Growth Rate (2013-2018)
    Figure Korea Anti-tumor Drug Sales and Growth Rate (2013-2018)
    Figure Korea Anti-tumor Drug Revenue (Million $) and Growth Rate (2013-2018)
    Figure India Anti-tumor Drug Sales and Growth Rate (2013-2018)
    Figure India Anti-tumor Drug Revenue (Million $) and Growth Rate (2013-2018)
    Figure Southeast Asia Anti-tumor Drug Sales and Growth Rate (2013-2018)
    Figure Southeast Asia Anti-tumor Drug Revenue (Million $) and Growth Rate (2013-2018)
    Figure Australia Anti-tumor Drug Sales and Growth Rate (2013-2018)
    Figure Australia Anti-tumor Drug Revenue (Million $) and Growth Rate (2013-2018)
    Table South America Anti-tumor Drug Sales by Country (2013-2018)
    Figure South America Anti-tumor Drug Sales Market Share by Country (2013-2018)
    Table South America Anti-tumor Drug Revenue by Country (2013-2018)
    Figure South America Anti-tumor Drug Revenue Market Share by Country (2013-2018)
    Figure South America Anti-tumor Drug Sales Market Share by Type in 2018
    Figure South America Anti-tumor Drug Sales Market Share by Application in 2018
    Figure Brazil Anti-tumor Drug Sales and Growth Rate (2013-2018)
    Figure Brazil Anti-tumor Drug Revenue (Million $) and Growth Rate (2013-2018)
    Figure Argentina Anti-tumor Drug Sales and Growth Rate (2013-2018)
    Figure Argentina Anti-tumor Drug Revenue (Million $) and Growth Rate (2013-2018)
    Figure Colombia Anti-tumor Drug Sales and Growth Rate (2013-2018)
    Figure Colombia Anti-tumor Drug Revenue (Million $) and Growth Rate (2013-2018)
    Figure Chile Anti-tumor Drug Sales and Growth Rate (2013-2018)
    Figure Chile Anti-tumor Drug Revenue (Million $) and Growth Rate (2013-2018)
    Table Middle East & Africa Anti-tumor Drug Sales by Country (2013-2018)
    Figure Middle East & Africa Anti-tumor Drug Sales Market Share by Country (2013-2018)
    Table Middle East & Africa Anti-tumor Drug Revenue by Country (2013-2018)
    Figure Middle East & Africa Anti-tumor Drug Revenue Market Share by Country (2013-2018)
    Figure Middle East & Africa Anti-tumor Drug Sales Market Share by Type in 2018
    Figure Middle East & Africa Anti-tumor Drug Sales Market Share by Application in 2018
    Figure Egypt Anti-tumor Drug Sales and Growth Rate (2013-2018)
    Figure Egypt Anti-tumor Drug Revenue (Million $) and Growth Rate (2013-2018)
    Figure Saudi Arabia Anti-tumor Drug Sales and Growth Rate (2013-2018)
    Figure Saudi Arabia Anti-tumor Drug Revenue (Million $) and Growth Rate (2013-2018)
    Figure South Africa Anti-tumor Drug Sales and Growth Rate (2013-2018)
    Figure South Africa Anti-tumor Drug Revenue (Million $) and Growth Rate (2013-2018)
    Figure Nigeria Anti-tumor Drug Sales and Growth Rate (2013-2018)
    Figure Nigeria Anti-tumor Drug Revenue (Million $) and Growth Rate (2013-2018)
    Table Company Snapshot of Roche
    Table Anti-tumor Drug Introduction of Roche
    Table Anti-tumor Drug Sales, Price, Revenue, Gross Margin and Market Share of Roche (2016-2018)
    Table Industrial Chain of Anti-tumor Drug
    Table Manufacturing Cost Structure of Anti-tumor Drug
    Table General Manufacturing Process of Anti-tumor Drug
    Table Leading Distributors/Dealers of Anti-tumor Drug
    Table Leading Consumers of Anti-tumor Drug
    Figure Global Anti-tumor Drug Sales and Growth Rate Forecast (2019-2028)
    Figure Global Anti-tumor Drug Revenue and Growth Rate Forecast (2019-2028)
    Table Global Anti-tumor Drug Market Size and CAGR Forecast by Region (2019-2028)
    Table Global Anti-tumor Drug Market Size and CAGR Forecast by Type (2019-2028)
    Table Global Anti-tumor Drug Market Size and CAGR Forecast by Application (2019-2028)
    Table Global Anti-tumor Drug Market Size and CAGR Forecast by Sales Channel (2019-2028)

    
 



To request a free sample copy of this report, please complete the form below.

We never share your personal data. Privacy policy
Interested in this report? Get your FREE sample now! Get a Free Sample
Choose License Type
Single User - US $2500
Multi User - US $5000
Hexareeasearch Know

Did you know?

Research Assistance

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Why to buy from us

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Quality assurance

A testimonial for service excellence represented in the form of BBB "A" Accreditation.

Information security

Your personal and confidential information is safe and secure.

verify